Jafron Biomedical Co.,Ltd.’s Net Profit Dropped 26.3% in 2022

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 880.9 million yuan in 2022, down 26.3% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, down 6.9% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 33.7%.